Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000333754 | SCV000399297 | likely benign | Brittle cornea syndrome 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001514436 | SCV000730943 | benign | not provided | 2019-03-11 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001514436 | SCV001722281 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000333754 | SCV002514262 | benign | Brittle cornea syndrome 1 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278443 | SCV002565310 | benign | Ehlers-Danlos syndrome | 2022-06-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002429272 | SCV002743086 | benign | Cardiovascular phenotype | 2019-05-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |